Dolby Laboratories (DLB) closed at $64.67 on November 10, 2026, down 0.2% from the previous close, on volume of 478,026 shares (30-day average 617,505).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results
PRNewswire (Mon, 12-Oct 8:30 AM ET)
PRNewswire (Wed, 7-Oct 9:01 AM ET)
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
PRNewswire (Wed, 23-Sep 8:00 PM ET)
Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan
PRNewswire (Tue, 15-Sep 7:00 PM ET)
Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026
PRNewswire (Thu, 10-Sep 9:00 AM ET)
Dolby Laboratories Announces Leadership Transition
PRNewswire (Thu, 27-Aug 9:01 AM ET)
Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level
Business Wire (Fri, 21-Aug 5:18 AM ET)
Seattle Seahawks Become First Team to Bring Dolby OptiView with Dolby Vision to Fans
PRNewswire (Thu, 13-Aug 9:00 AM ET)
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
Dolby Laboratories trades on the NYSE stock market under the symbol DLB.
As of November 10, 2026, DLB stock price declined to $64.67 with 478,026 million shares trading.
DLB has a beta of 0.36, meaning it tends to be less sensitive to market movements. DLB has a correlation of 0.02 to the broad based SPY ETF.
DLB has a market cap of $6.06 billion. This is considered a Mid Cap stock.
Last quarter Dolby Laboratories reported $305 million in Revenue and $.69 earnings per share. This fell short of revenue expectation by $-7 million and exceeded earnings estimates by $.07.
In the last 3 years, DLB traded as high as $90.06 and as low as $48.26.
The top ETF exchange traded funds that DLB belongs to (by Net Assets): IJH, VTI, SDVY, VGT, VB.
DLB has underperformed the market in the last year with a return of +1.5%, while SPY returned +12.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in DLB shares. However, DLB has outperformed the market in the last 3 month and 2 week periods, returning +5.3% and +2.5%, while SPY returned -2.8% and -2.0%, respectively. This indicates DLB has been having a stronger performance recently.
DLB support price is $63.47 and resistance is $66.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DLB shares will trade within this expected range on the day.
